Última actualización :
27/11/2024
InfoStab
Infostab
Lista de la molécula
Lista de la molécula
Listas recapitulativas
Listas recapitulativas
Búsqueda de compatibilidades
Búsqueda de compatibilidades
Tabla de compatibilidad en Y
Tabla de compatibilidad en Y
Bibliografía
Bibliografía
Los equipos de investigación
Los equipos de investigación
valistab
valistab
póster
póster
Vínculos
Vínculos
patrocinadores
patrocinadores
Autores
Autores
Manual de instruciones
Manual de instruciones
Boletín de noticias
Boletín de noticias
Los equipos de investigación - University of Rochester Medical Center, Department of Pharmacy   pdf  
Estados Unidos de América
hospital
University of Rochester Medical Center, Department of Pharmacy
Rochester
Bibliografía   Bibliografía   (13)  
1
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspensions.
Atkins J.R, Lull M.E, Decker A.S, Hutchinson D.J. (dhutchinson@sjfc.edu)
Int J Pharm Compound - 2018 - ;22,4:326-328
2
In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes.
Reindel K, Zhao F, Hughes S, Dave V. (vdave@sjfc.edu)
Hosp Pharm - 2017 - ;52,11:752-760
3
Stability of codeine phosphate in an extemporaneously compounded syrup
Dentinger PJ, Swenson CF. ()
Am J Health-Syst Pharm - 2007 - Dentinger PJ, Swenson CF
4
Stability of nifedipine in an extemporaneously compounded oral solution
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2003 - ; 60: 1019-1022.
5
Stability of valganciclovir in an extemporaneously compounded oral liquid
Anaizi NH, Dentinger PJ, Swenson CF. ()
Am J Health-Syst Pharm - 2002 - ; 59: 1267-1270.
6
Stability of pantoprazole in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2002 - ; 59: 953-956.
7
Stability of amphotericin B in an extemporaneously compounded oral suspension.
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2001 - ; 58: 1021-1024.
8
Stability of famotidine in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2000 - ; 57: 1340-1342.
9
Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid
Swenson CF, Dentinger PJ, Anaizi NH. ()
Am J Health-Syst Pharm - 1999 - ; 56: 2224-2226.
10
Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid
Anaizi NH, Swenson CF, Dentinger PJ. ()
Am J Health-Syst Pharm - 1998 - ; 55: 926-929.
11
Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution
Anaizi NH, Swenson CF, Dentinger PJ. ()
Am J Health-Syst Pharm - 1997 - ; 54: 549-553.
12
Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid
Metras JI, Swenson CF, McDermott MP. ()
Am J Hosp Pharm - 1992 - ; 49: 1720-1724.
13
Instability of aqueous captopril solutions
Anaizi NH, Swenson C. ()
Am J Hosp Pharm - 1979 - ; 50: 486-488.

Lista de la molécula   moléculas estudiadas   (12)  
Antifúngico Solución Oral Amphotericin B
Varios Solución Oral Benzoate sodium
Antihipertensor Solución Oral Captopril
Antálgico Solución Oral Codeine phosphate
Antiepiléptico Solución Oral Eslicarbazepine acetate
Antihistamínico H2 Solución Oral Famotidine
Inmunosupresor Solución Oral Mycophenolate mofetil
Varios Gotas oculares N-acetylcysteine
Vasodilatador Solución Oral Nifedipine
Inhibidor de la bomba de protones Solución Oral Pantoprazole sodium
Antiarrítmico Solución Oral Procainamide hydrochloride
Antiviral Solución Oral Valganciclovir
  Mentions Légales